Centrient Pharmaceuticals to Acquire Astral SteriTech, Expanding its Product Portfolio with Sterile Injectable Antibiotic Finished Dosage Forms

Rotterdam, the Netherlands, Feb. 15 (Korea Bizwire) – Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”), a leading international manufacturer specialised in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens [...]